Charles Schwab’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-154,667
Closed -$1.4M 3716
2024
Q1
$1.4M Buy
154,667
+5,241
+4% +$47.4K ﹤0.01% 2696
2023
Q4
$1.62M Buy
149,426
+10,497
+8% +$114K ﹤0.01% 2675
2023
Q3
$1.12M Buy
138,929
+3,864
+3% +$31.1K ﹤0.01% 2761
2023
Q2
$1.47M Buy
135,065
+115,496
+590% +$1.25M ﹤0.01% 2645
2023
Q1
$135K Sell
19,569
-5,091
-21% -$35.1K ﹤0.01% 3212
2022
Q4
$98.1K Buy
24,660
+11,851
+93% +$47.2K ﹤0.01% 3261
2022
Q3
$86K Hold
12,809
﹤0.01% 3237
2022
Q2
$62K Sell
12,809
-82,238
-87% -$398K ﹤0.01% 3361
2022
Q1
$889K Buy
95,047
+2,281
+2% +$21.3K ﹤0.01% 2902
2021
Q4
$1.1M Hold
92,766
﹤0.01% 2870
2021
Q3
$1.06M Buy
92,766
+1,721
+2% +$19.6K ﹤0.01% 2857
2021
Q2
$1.63M Buy
91,045
+16,213
+22% +$291K ﹤0.01% 2784
2021
Q1
$1.16M Buy
74,832
+13,412
+22% +$208K ﹤0.01% 2809
2020
Q4
$750K Buy
61,420
+3,954
+7% +$48.3K ﹤0.01% 2863
2020
Q3
$739K Buy
57,466
+6,241
+12% +$80.3K ﹤0.01% 2760
2020
Q2
$521K Buy
51,225
+2,060
+4% +$21K ﹤0.01% 2813
2020
Q1
$400K Buy
49,165
+17,475
+55% +$142K ﹤0.01% 2789
2019
Q4
$274K Hold
31,690
﹤0.01% 2993
2019
Q3
$196K Hold
31,690
﹤0.01% 3041
2019
Q2
$527K Buy
31,690
+7,815
+33% +$130K ﹤0.01% 2786
2019
Q1
$400K Buy
23,875
+4,525
+23% +$75.8K ﹤0.01% 2841
2018
Q4
$223K Hold
19,350
﹤0.01% 3003
2018
Q3
$774K Buy
19,350
+2,400
+14% +$96K ﹤0.01% 2701
2018
Q2
$480K Buy
+16,950
New +$480K ﹤0.01% 2818